Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

Dialysis firm Fresenius Medical Care reports Q1 slightly below expectations

Published 04/05/2022, 06:10
Updated 04/05/2022, 07:01
© Reuters. FILE PHOTO: The Headquarters of Fresenius is pictured in Bad Homburg near Frankfurt February 24, 2010. Fresenius is a global health care company with products and services for dialysis, hospitals and medical care of patients at home.    REUTERS/Johannes E
FREG
-
FMS
-

(Reuters) - German dialysis specialist Fresenius Medical Care on Wednesday posted a lower-than-expected net income for the first quarter, weighed down by high coronavirus-related deaths among its patients and elevated labour costs in the U.S.

The quarterly net income of the world's largest provider of dialysis treatments dropped 37% to 157 million euros ($165.09 million), against 159 million euros expected by analysts polled by Vara Research.

The group maintained its earlier forecast for revenue and net income growth at low- to mid-single-digit percentage rates in 2022.

($1 = 0.9510 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.